Kevin Rakin - Founder and Partner @ HighCape Partners

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Founder and Partner
Primary Organization
HighCape Partners

Location Baltimore, Maryland, United States
Regions Greater Baltimore-Maryland Area, East Coast, Southern US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Kevin Rakin is a Partner and Co-founder at HighCape Capital and was a CEO at Aziyo Biologics. He attended Columbia Business School and the University of Cape Town.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Cybrexa Therapeutics	HighCape Partners	—	Series B - Cybrexa Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Alphina Therapeutics	HighCape Partners	Yes	Pre Seed Round - Alphina Therapeutics	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Kevin Rakin

is the

Founder and Partner

HighCape Partners

. Additionally,

Kevin Rakin

has had

past job as the

CEO

Elutia

HighCape Partners Founder and PartnerJan 2013

Organization Name	Title At Company	Start Date	End Date
Elutia	CEO	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Kevin Rakin

holds

board and advisor roles as

Board Chairman

Cybrexa Therapeutics

and

Board Member

Wellinks (formerly Convexity Scientific)

Cybrexa Therapeutics Board Chairman
Wellinks (formerly Convexity Scientific) Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Venture Stage Investors with Investments in Maryland	24,068
Baltimore Seed Stage Investors	93,528
Early Stage Venture Investors with Investments in Maryland	15,340
Maryland Private Equity Firms	69,818
Post IPO Investors with Investments in Southern US	18,763
Maryland Investors	18,397
Greater Baltimore-Maryland Area Seed Stage Investors	89,652
Greater Baltimore-Maryland Area Investors	34,922
Maryland Seed Stage Investors	57,991
Maryland Venture Stage Investors	71,199